15 min listen
COVID-19 Vaccine Approval and the FDA
ratings:
Length:
36 minutes
Released:
Sep 23, 2020
Format:
Podcast episode
Description
Hydroxychloroquine and convalescent plasma approvals by the FDA under Emergency Use Authorization (EUA) protocols have raised concerns the agency is under withering political pressure to fast-track a COVID-19 vaccine before it is proven safe and effective. Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety. Recorded September 18, 2020. Related Article: Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
Released:
Sep 23, 2020
Format:
Podcast episode
Titles in the series (100)
A Vision for Patient-Centered Health Information Systems: Interview with Alex H. Krist, MD, MPH, author of A Vision for Patient-Centered Health Information Systems by JAMA Author Interviews